Cite
Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays.
MLA
Wu, Yunlong, et al. “Identification of Novel EZH2 Inhibitors through Pharmacophore-Based Virtual Screening and Biological Assays.” Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, Aug. 2016, pp. 3813–17. EBSCOhost, https://doi.org/10.1016/j.bmcl.2016.05.018.
APA
Wu, Y., Hu, J., Ding, H., Chen, L., Zhang, Y., Liu, R., Xu, P., Du, D., Lu, W., Liu, J., Liu, Y., Liu, Y.-C., Lu, J., Zhang, J., Yao, Z., & Luo, C. (2016). Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays. Bioorganic & Medicinal Chemistry Letters, 26(15), 3813–3817. https://doi.org/10.1016/j.bmcl.2016.05.018
Chicago
Wu, Yunlong, Junchi Hu, Hong Ding, Limin Chen, Yuanyuan Zhang, Rongfeng Liu, Pan Xu, et al. 2016. “Identification of Novel EZH2 Inhibitors through Pharmacophore-Based Virtual Screening and Biological Assays.” Bioorganic & Medicinal Chemistry Letters 26 (15): 3813–17. doi:10.1016/j.bmcl.2016.05.018.